115 related articles for article (PubMed ID: 32661468)
1. Potential clinical value of interleukin-31 and interleukin-33 with their receptors expression as diagnostic and predictive factors in endometrial cancer: a case-control study.
Zeng X; Li J; Kang LN; Xi MR; Liao GD
Int J Clin Exp Pathol; 2020; 13(6):1324-1332. PubMed ID: 32661468
[No Abstract] [Full Text] [Related]
2. Evaluation of PTEN and CD4+FOXP3+ T cell expressions as diagnostic and predictive factors in endometrial cancer: A case control study.
Xi Z; Jing L; Le-Ni K; Zhu L; Ze-Wen D; Hui Y; Ming-Rong X; Guang-Dong L
Medicine (Baltimore); 2019 Jul; 98(30):e16345. PubMed ID: 31348233
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Serum Interleukin-31 and Interleukin-33 Levels in Patients of Endometrial Cancer: A Case Control Study.
Zeng X; Zhang Z; Gao QQ; Wang YY; Yu XZ; Zhou B; Xi MR
Dis Markers; 2016; 2016():9262919. PubMed ID: 27340318
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical signification of IL-10 and IL-17 in endometrial cancer].
Li L; Cheng C; Duan RQ; Quan Y; Wang KN; He YD; Xi MR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 45(5):793-6. PubMed ID: 25341342
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours.
Browne A; Sriraksa R; Guney T; Rama N; Van Noorden S; Curry E; Gabra H; Stronach E; El-Bahrawy M
Cytokine; 2013 Oct; 64(1):413-21. PubMed ID: 23727325
[TBL] [Abstract][Full Text] [Related]
6. High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.
Bellone S; Watts K; Cane' S; Palmieri M; Cannon MJ; Burnett A; Roman JJ; Pecorelli S; Santin AD
Gynecol Oncol; 2005 Jul; 98(1):92-8. PubMed ID: 15904949
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of expression of interleukin-8 related to myometrial invasion with angiogenesis in uterine endometrial cancers.
Fujimoto J; Aoki I; Khatun S; Toyoki H; Tamaya T
Ann Oncol; 2002 Mar; 13(3):430-4. PubMed ID: 11996475
[TBL] [Abstract][Full Text] [Related]
8. Association between visceral fat, IL-8 and endometrial cancer.
Ciortea R; Mihu D; Mihu CM
Anticancer Res; 2014 Jan; 34(1):379-83. PubMed ID: 24403491
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of pretreatment serum levels of VEGF and its receptors, IL- 8, and their prognostic value in type I and II endometrial cancer patients.
Kotowicz B; Fuksiewicz M; Jonska-Gmyrek J; Berezowska A; Radziszewski J; Bidzinski M; Kowalska M
PLoS One; 2017; 12(10):e0184576. PubMed ID: 28991928
[TBL] [Abstract][Full Text] [Related]
10. IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients.
Ma Y; Ren Y; Dai ZJ; Wu CJ; Ji YH; Xu J
Adv Clin Exp Med; 2017; 26(3):421-426. PubMed ID: 28791816
[TBL] [Abstract][Full Text] [Related]
11. Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction.
Zhang K; Zhang XC; Mi YH; Liu J
Chin Med J (Engl); 2013; 126(19):3628-31. PubMed ID: 24112154
[TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin-1 and interleukin-1 receptor antagonists in endometrial cancer.
Van Le L; Haskill S; Jaffe GJ; Fowler WC
Gynecol Oncol; 1991 Aug; 42(2):161-4. PubMed ID: 1832651
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated Interleukin -33/ST2 Pathway Perpetuates Chronic Inflammation in Hashimoto's Thyroiditis.
Wang X; Shao X; Liu X; Qin Q; Xu J; Zhang JA
Endocr Metab Immune Disord Drug Targets; 2019; 19(7):1012-1021. PubMed ID: 30819087
[TBL] [Abstract][Full Text] [Related]
14. Endometrial expression and secretion of interleukin-6 throughout the menstrual cycle.
von Wolff M; Thaler CJ; Zepf C; Becker V; Beier HM; Strowitzki T
Gynecol Endocrinol; 2002 Apr; 16(2):121-9. PubMed ID: 12012622
[TBL] [Abstract][Full Text] [Related]
15. Expression of IL-1α and IL-6 is Associated with Progression and Prognosis of Human Cervical Cancer.
Song Z; Lin Y; Ye X; Feng C; Lu Y; Yang G; Dong C
Med Sci Monit; 2016 Nov; 22():4475-4481. PubMed ID: 27866212
[TBL] [Abstract][Full Text] [Related]
16. Expression of leukaemia inhibitory factor and interleukin 15 in endometrium of women with recurrent implantation failure after IVF; correlation with the number of endometrial natural killer cells.
Mariee N; Li TC; Laird SM
Hum Reprod; 2012 Jul; 27(7):1946-54. PubMed ID: 22537815
[TBL] [Abstract][Full Text] [Related]
17. Endometrial hyperplasia-related inflammation: its role in the development and progression of endometrial hyperplasia.
Kubyshkin AV; Aliev LL; Fomochkina II; Kovalenko YP; Litvinova SV; Filonenko TG; Lomakin NV; Kubyshkin VA; Karapetian OV
Inflamm Res; 2016 Oct; 65(10):785-94. PubMed ID: 27312112
[TBL] [Abstract][Full Text] [Related]
18. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
[TBL] [Abstract][Full Text] [Related]
19. Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expressions in type 2 endometrial cancer.
Kucukgoz Gulec U; Kilic Bagir E; Paydas S; Guzel AB; Gumurdulu D; Vardar MA
Arch Gynecol Obstet; 2019 Aug; 300(2):377-382. PubMed ID: 31076855
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid mediates interleukin-8 expression in human endometrial stromal cells through its receptor and nuclear factor-kappaB-dependent pathway: a possible role in angiogenesis of endometrium and placenta.
Chen SU; Lee H; Chang DY; Chou CH; Chang CY; Chao KH; Lin CW; Yang YS
Endocrinology; 2008 Nov; 149(11):5888-96. PubMed ID: 18617617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
